- call +1-201-465-4211
- email sales@mrinsights.biz
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Scope of the Report:
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
The worldwide market for Generic Drugs is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 369400 million US$ in 2024, from 210800 million US$ in 2019, according to a new study.
This report focuses on the Generic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Market Segment by Applications, can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Drugs, with price, sales, revenue and global market share of Generic Drugs in 2017 and 2018.
Chapter 3, the Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Simple Generic Drugs
1.2.2 Super Generic Drugs
1.2.3 Biosimilars
1.3 Market Analysis by Applications
1.3.1 CNS
1.3.2 Cardiovascular
1.3.3 Genitourinary/Hormonal Drugs
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Generic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis - Sandoz
2.2.1 Business Overview
2.2.2 Generic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Generic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Generic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Aspen
2.5.1 Business Overview
2.5.2 Generic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Fresenius Kabi
2.6.1 Business Overview
2.6.2 Generic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer (Hospira)
2.7.1 Business Overview
2.7.2 Generic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Generic Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Aurobindo
2.9.1 Business Overview
2.9.2 Generic Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lupin
2.10.1 Business Overview
2.10.2 Generic Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Dr. Reddy's
2.11.1 Business Overview
2.11.2 Generic Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Apotex
2.12.1 Business Overview
2.12.2 Generic Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Cipla
2.13.1 Business Overview
2.13.2 Generic Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 ENDO (Par Pharmaceutical)
2.14.1 Business Overview
2.14.2 Generic Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Stada Arzneimittel
2.15.1 Business Overview
2.15.2 Generic Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Krka Group
2.16.1 Business Overview
2.16.2 Generic Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Nichi-Iko Pharmaceutical
2.17.1 Business Overview
2.17.2 Generic Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Valeant
2.18.1 Business Overview
2.18.2 Generic Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Zydus Cadila
2.19.1 Business Overview
2.19.2 Generic Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Hikma
2.20.1 Business Overview
2.20.2 Generic Drugs Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Generic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Generic Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Generic Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Generic Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Generic Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Generic Drugs Market Analysis by Regions
4.1 Global Generic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Generic Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Generic Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Generic Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Generic Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Generic Drugs Sales and Growth Rate (2014-2019)
4.5 South America Generic Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Generic Drugs Sales and Growth Rate (2014-2019)
5 North America Generic Drugs by Country
5.1 North America Generic Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Generic Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Generic Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Generic Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Generic Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Generic Drugs Sales and Growth Rate (2014-2019)
6 Europe Generic Drugs by Country
6.1 Europe Generic Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Generic Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Generic Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Generic Drugs Sales and Growth Rate (2014-2019)
6.3 UK Generic Drugs Sales and Growth Rate (2014-2019)
6.4 France Generic Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Generic Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Generic Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Generic Drugs by Country
7.1 Asia-Pacific Generic Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Generic Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Generic Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Generic Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Generic Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Generic Drugs Sales and Growth Rate (2014-2019)
7.5 India Generic Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Generic Drugs Sales and Growth Rate (2014-2019)
8 South America Generic Drugs by Country
8.1 South America Generic Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Generic Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Generic Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Generic Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Generic Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Generic Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Generic Drugs by Countries
9.1 Middle East and Africa Generic Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Generic Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Generic Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Generic Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Generic Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Generic Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Generic Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Generic Drugs Sales and Growth Rate (2014-2019)
10 Global Generic Drugs Market Segment by Type
10.1 Global Generic Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Generic Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Generic Drugs Revenue and Market Share by Type (2014-2019)
10.2 Simple Generic Drugs Sales Growth and Price
10.2.1 Global Simple Generic Drugs Sales Growth (2014-2019)
10.2.2 Global Simple Generic Drugs Price (2014-2019)
10.3 Super Generic Drugs Sales Growth and Price
10.3.1 Global Super Generic Drugs Sales Growth (2014-2019)
10.3.2 Global Super Generic Drugs Price (2014-2019)
10.4 Biosimilars Sales Growth and Price
10.4.1 Global Biosimilars Sales Growth (2014-2019)
10.4.2 Global Biosimilars Price (2014-2019)
11 Global Generic Drugs Market Segment by Application
11.1 Global Generic Drugs Sales Market Share by Application (2014-2019)
11.2 CNS Sales Growth (2014-2019)
11.3 Cardiovascular Sales Growth (2014-2019)
11.4 Genitourinary/Hormonal Drugs Sales Growth (2014-2019)
11.5 Respiratory Sales Growth (2014-2019)
11.6 Rheumatology Sales Growth (2014-2019)
11.7 Diabetes Sales Growth (2014-2019)
11.8 Oncology Sales Growth (2014-2019)
11.9 Others Sales Growth (2014-2019)
12 Generic Drugs Market Forecast (2019-2024)
12.1 Global Generic Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Generic Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Generic Drugs Market Forecast (2019-2024)
12.2.2 Europe Generic Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Generic Drugs Market Forecast (2019-2024)
12.2.4 South America Generic Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Generic Drugs Market Forecast (2019-2024)
12.3 Generic Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Generic Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Generic Drugs Market Share Forecast by Type (2019-2024)
12.4 Generic Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Generic Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Generic Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Generic Drugs Picture
Table Product Specifications of Generic Drugs
Figure Global Sales Market Share of Generic Drugs by Types in 2018
Table Generic Dru
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
